David L. Narotsky

1.5k total citations · 1 hit paper
17 papers, 1.0k citations indexed

About

David L. Narotsky is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Molecular Biology. According to data from OpenAlex, David L. Narotsky has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in David L. Narotsky's work include Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Parathyroid Disorders and Treatments (4 papers) and Mechanical Circulatory Support Devices (3 papers). David L. Narotsky is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Parathyroid Disorders and Treatments (4 papers) and Mechanical Circulatory Support Devices (3 papers). David L. Narotsky collaborates with scholars based in United States. David L. Narotsky's co-authors include Adam Castaño, Sabahat Bokhari, Rachelle Morgenstern, Mathew S. Maurer, Susheel Kodali, Tamim Nazif, Omar Khalique, Torsten Vahl, Rebecca T. Hahn and Codruța Chiuzan and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

David L. Narotsky

15 papers receiving 997 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement

2017 440 citations Adam Castaño, David L. Narotsky et al. European Heart Journal profile →

Peers

Countries citing papers authored by David L. Narotsky

Since Specialization

Citations

This map shows the geographic impact of David L. Narotsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Narotsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Narotsky more than expected).

Fields of papers citing papers by David L. Narotsky

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Narotsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Narotsky. The network helps show where David L. Narotsky may publish in the future.

Co-authorship network of co-authors of David L. Narotsky

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Narotsky. A scholar is included among the top collaborators of David L. Narotsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Narotsky. David L. Narotsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Mortality of patients with ST-segment-elevation myocardial infarction without standard modifiable risk factors among patients without known coronary artery disease: Age-stratified and sex-related analysis from nationwide readmissions database 2010-2014 2023 ·SHILAP Revista de lepidopterología ·(unknown), Luke K. Kim, (unknown), Ilhwan Yeo, Jim W. Cheung, Dmitriy N. Feldman, Nivee Amin, David L. Narotsky, Parag Goyal, Stephen McCullough, Udhay Krishnan, Stuart Zarich, S. Chiu Wong, (unknown)	12
2	Thirty-Day Readmission Rates after Takotsubo Syndrome with or without Malignancy: A Nationwide Readmissions Database Analysis 2021 ·Journal of Clinical Medicine ·(unknown), Ilhwan Yeo, (unknown), Parag Goyal, Jim W. Cheung, Dmitriy N. Feldman, Stephen McCullough, Udhay Krishnan, David L. Narotsky, Harsimran Singh, Robert M. Minutello, Geoffrey Bergman, S. Chiu Wong, Luke K. Kim	4
3	TO LOAD OR NOT TO LOAD: CLOPIDOGREL IN DIFFUSE ALVEOLAR HEMMORRHAGE 2021 ·CHEST Journal ·(unknown), (unknown), Elyse LaFond, David L. Narotsky, (unknown)	0
4	UNVEILING OUTCOMES IN COEXISTING SEVERE AORTIC STENOSIS AND TRANSTHYRETIN CARDIAC AMYLOIDOSIS 2020 ·Journal of the American College of Cardiology ·Hannah Rosenblum, (unknown), David L. Narotsky, (unknown), Nadira Hamid, Rebecca T. Hahn, Susheel Kodali, Torsten Vahl, Tamim Nazif, Omar Khalique, Sabahat Bokhari, Prem Soman, João L. Cavalcante, Mathew S. Maurer, Adam Castaño	13
5	Unveiling outcomes in coexisting severe aortic stenosis and transthyretin cardiac amyloidosis 2020 ·European Journal of Heart Failure ·Hannah Rosenblum, Ahmad Masri, David L. Narotsky, Jeff Goldsmith, Nadira Hamid, Rebecca T. Hahn, Susheel Kodali, Torsten Vahl, Tamim Nazif, Omar Khalique, Sabahat Bokhari, Prem Soman, João L. Cavalcante, Mathew S. Maurer, Adam Castaño	84
6	Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement breakdown → 2017 ·European Heart Journal ·Adam Castaño, David L. Narotsky, Nadira Hamid, Omar Khalique, Rachelle Morgenstern, Albert J. DeLuca, Jonah Rubin, Codruța Chiuzan, Tamim Nazif, Torsten Vahl, Isaac George, Susheel Kodali, Martin B. Leon, Rebecca T. Hahn, Sabahat Bokhari, Mathew S. Maurer	440
7	TRANSTHYRETIN CARDIAC AMYLOIDOSIS IS PREVALENT AMONG MEN WITH SEVERE AORTIC STENOSIS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT 2016 ·Journal of the American College of Cardiology ·Adam Castaño, David L. Narotsky, Susheel Kodali, Tamim Nazif, Isaac George, Torsten Vahl, Nadira Hamid, Rebecca T. Hahn, Rachelle Morgenstern, Sabahat Bokhari, Mathew S. Maurer	0
8	Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging 2016 ·Canadian Journal of Cardiology ·David L. Narotsky, Adam Castaño, Jonathan W. Weinsaft, Sabahat Bokhari, Mathew S. Maurer	28
9	Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging 2016 ·JAMA Cardiology ·Adam Castaño, (unknown), David L. Narotsky, Jeff Goldsmith, Richard L. Weinberg, Rachelle Morgenstern, Ted Pozniakoff, Frederick L. Ruberg, Edward J. Miller, John L. Berk, Angela Dispenzieri, Martha Grogan, Geoffrey B. Johnson, Sabahat Bokhari, Matthew J. Maurer	275
10	Survival Following Veno-Venous Extracorporeal Membrane Oxygenation and Mortality in a Diverse Patient Population 2015 ·Journal of ExtraCorporeal Technology ·(unknown), David L. Narotsky, Ming Liao, Heidi Mochari‐Greenberger, Jürgen Beck, Linda B. Mongero, Matthew Bacchetta	6
11	The prevalence of long QT interval in post-operative intensive care unit patients 2015 ·Journal of Clinical Monitoring and Computing ·Julius Cuong Pham, (unknown), David L. Narotsky, Todd Dorman, Bradford D. Winters	7
12	Duration of conventional cardiopulmonary resuscitation prior to extracorporeal cardiopulmonary resuscitation and survival among adult cardiac arrest patients. 2015 ·Perfusion ·(unknown), David L. Narotsky, Heidi Mochari‐Greenberger, Ming Liao, Linda B. Mongero, Jürgen Beck, Matthew Bacchetta	5
13	Abstract 13456: Screening for Transthyretin Cardiac Amyloidosis Using 99mTc-Pyrophosphate Scintigraphy in Patients Undergoing Transcatheter Aortic Valve Replacement 2015 ·Circulation ·David L. Narotsky, Susheel Kodali, (unknown), Sabahat Bokhari, Nadira Hamid, Ted Pozniakoff, Richard L. Weinberg, Tamim Nazif, Isaac George, Torsten Vahl, Rebecca T. Hahn, Adam Castaño	3
14	Short-term and longer-term survival after veno-arterial extracorporeal membrane oxygenation in an adult patient population: does older age matter? 2015 ·Perfusion ·David L. Narotsky, (unknown), Heidi Mochari‐Greenberger, Jürgen Beck, Ming Liao, Linda B. Mongero, Matthew Bacchetta	20
15	25‐Hydroxyvitamin D and Ankle‐Brachial Blood Pressure Index in Adults without Peripheral Artery Disease 2014 ·Clinical and Translational Science ·Muhammad Amer, David L. Narotsky, Rehan Qayyum	5
16	Temporal and geographic trends in celiac disease publications 2012 ·European Journal of Gastroenterology & Hepatology ·David L. Narotsky, Peter H.R. Green, Benjamin Lebwohl	33
17	Mortality Among Marathon Runners in the United States, 2000-2009 2012 ·The American Journal of Sports Medicine ·Simon C. Mathews, David L. Narotsky, David L. Bernholt, Matthew N.P. Vogt, Yu‐Hsiang Hsieh, Peter J. Pronovost, Julius Cuong Pham	75

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact